Dec 2025 Appendix 4D and Half Year Accounts
Filed with ASX · · 23 pages · English
Summary by 6ix AI
The report indicates a decline in revenue from ordinary activities and a loss attributable to the owners of the company, reflecting ongoing challenges in the market. No dividends were declared during this financial period, and the report highlights a focus on transitioning to a recurring revenue model in healthcare software solutions. The directors express confidence in the company's ability to meet its obligations and continue operations as a going concern despite the reported losses.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Global Health
- Amendment Cover page for Appendix 4C December 25 QTR
- GLH Appendix 4C December 25 QTR Cash Flow Report
- GLH 4C September 25 QTR Cash Flow Report
- FY 2025 Results Summary
- 2025 Appendix 4E and Full Year Statutory Accounts
Later from Global Health
- Global Health Limited HY 2026 Results Update for Investors
- March-26 QTR Business Activity Report and Appendix 4C
- June 2026 Quarterly Business Activity report and Appendix 4C
- 2026 Appendix 4E and Full Year Statutory Accounts
- 2026 Appendix 4G
Follow Global Health into a list and get an email when it puts out news.
Follow Global Health